Singapore Medical Device Registration

Singapore stands at the forefront of medical innovation in Asia, offering a stable, transparent, and internationally aligned regulatory environment. For medical device and IVD manufacturers looking to enter the high-potential Singapore market, understanding and complying with the Health Sciences Authority (HSA) requirements is essential to a success.

Cisema supports your full journey through medical device registration in Singapore, from determining risk class and preparing technical documentation, to securing regulatory approval and maintaining post-market compliance. As your licensed Authorized Representative (AR) or Marketing Authorization Holder (MAH) in Singapore, we manage your product registration, act as your legal interface with the authorities, and ensure your product remains compliant with the Health Products Act.

Whether you're launching a new product, registering class B, class C, or class D medical devices in Singapore, or managing submissions involving active implantable devices, standalone medical mobile applications or in-vitro diagnostics, we bring local expertise and international coordination to every step. Our services cover everything from device description and risk analysis to compliance with essential principles, alignment with overseas reference regulatory agencies, and inspection-ready quality management system support.

Medical Device Registration in Singapore
Singapore Medical Device Registration

Our Services for Medical Device Registration in Singapore

Cisema manages the entire product registration process with the Health Sciences Authority HSA, aligning your strategy with current local and ASEAN regulatory requirements.

Regulatory Strategy & Classification

Determine registration class and risk class under GN-13 guidelines
Evaluate claims and intended use under the Health Products Act
Recommend an appropriate route such as immediate, abridged, expedited, or full evaluation
Develop a timeline and documentation roadmap including device description and validation planning and testing

Technical Documentation & Dossier Preparation

Develop a timeline and documentation roadmap including device description and validation planning and testing
Translate and localize IFUs, labels, and product documents, identifying gaps and recommending corrective actions
Draft declarations, risk analysis, and conformity statements
Ensure alignment with the HSA’s essential principles which are used to evaluate conformity.

Registration Application & Submission

Register and manage submissions through the MEDICS portal
Act as your point of contact for authority interactions, HSA- accredited labs or MOH partners for performance verification and clinical evaluations especially for IVDs
Sample management, testing coordination and import permits (if required)
Submit responses to deficiency letters or additional information requests
Provide real-time updates on submission progress

Post-Approval Services

Submit change notifications, renewals, and scope updates before the expiry date
Manage vigilance activities such as FSCA and adverse event reporting
Maintain HSA compliance across your product lifecycle

Optional Add-Ons

Apply under the Priority Review Scheme or Special Access Route (SAR)
Provide consultation for reclassification or ASEAN regional rollout.

Authorized Representative (AR) Services in Singapore

Foreign manufacturers of IVDs and medical devices in Singapore must appoint a local authorized representative to serve as the legal applicant and regulatory liaison. Cisema is fully licensed to represent your products before the Health Sciences Authority, ensuring you meet all registration and post-market obligations.

Legal License Holder

Maintain and update your product registration in the MEDICS system
Communicate directly with the HSA on your behalf

Distributor LoAs

Listing your selected commercial partners in the MEDICS system
Allow distributor changes without re-registration

Regulatory Compliance

Monitor HSA announcements and policy changes
Submit notification change requests and label or IFU updates in advance

Post-Market Vigilance

Oversee adverse event reporting and product recalls
Coordinate Field Safety Corrective Actions (FSCA) and post-market surveillance

Conformity Assessment Bodies Collaboration

Assist with ASEAN and Asia Pacific expansion planning and device classification reviews
Support implementation of a compliant quality management system

Regulatory Strategy

Collaborate with your regulatory and commercial teams across regions
Offer multilingual support and real-time updates.

Quality Control Inspection Services for Medical Devices & IVDs in Singapore

Cisema’s quality control inspection services support your Singapore medical device & IVD operations by verifying compliance with HSA and global quality expectations. We ensure readiness for local distribution, regional supply, or internal audits.

Incoming Goods Inspections

Confirm product identity, quantity, and packaging integrity
Review labeling, certificates, and shipping documents
Verify storage and handling conditions for compliance

In-Process Quality Monitoring

Conduct on-site process checks during manufacturing or repackaging
Evaluate hygiene conditions, batch consistency, and traceability
Monitor SOP implementation and documentation practices

Final Product Release Inspections

Perform Acceptance Quality Limit-based sampling and functional testing
Confirm accuracy of IFUs and labeling
Approve readiness for market release

Special Inspection Projects

Assist with audit preparation for HSA, ISO 13485, or MDSAP
Validate reworked products, returns, or quarantined stock
Verify capital equipment serial numbers or manage recall sample checks

Why Work with Cisema?

Local expertise with global reach

Our bilingual teams bridge international quality standards with local regulations

Proven track record

Over 20 years supporting market approvals and compliance in China and Asia Pacific

End-to-end solutions

From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle

Industry breadth

Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Role of a China Agent

Other Markets We Support for Medical Device & IVD Registration

In addition to Singapore, Cisema supports IVD and device registration, regulatory representation, and quality inspection services in:

China

Hong Kong SAR

Malaysia

Vietnam

Taiwan

Philippines

Indonesia

South Korea

Thailand

Latest Insights

View More

China Expands MRI Registration Requirements Under New 2026 Review Guideline

Manufacturers seeking MRI registration in China must meet expanded technical, software, and validation requirements.

July 16, 2026
China Expands MRI Registration Requirements Under New 2026 Review Guideline
Chinese male MRI technician in a clinical, sterile medical imaging room. The man has a warm, focused expression and is wearing a dark blue medical-style t-shirt

China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

China's new BCI medical device guidance establishes classification and naming principles, giving manufacturers a clearer pathway to NMPA registration.

July 14, 2026
China Releases First Regulatory Guidance for Brain-Computer Interface Medical Devices

Singapore HSA Implements CMC Declaration Requirement Following eCTD Adoption

HSA now requires CMC validity declarations and accepts eCTD submissions, strengthening therapeutic product registration requirements.

July 2, 2026
Singapore HSA Implements CMC Declaration Requirement Following eCTD Adoption
medium shot of a Singaporean male worker inside a clean, modern manufacturing facility.

Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration

New Hainan MPA guidance clarifies how Lecheng real-world evidence can support imported product registration, labeling updates, and post-approval activities

July 2, 2026
Hainan MPA Issues Trial Lecheng Real-World Data Guideline for Imported Drug & Medical Device Registration
A clinical trial in Hainan, China, inside a clinical research consultation room at a  hospital. A Chinese doctor in a white lab coat seated across from an adult study participant discussing routine trial procedures, a second researcher reviewing data.

Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026

MDA will issue only electronic establishment licenses, affecting medical device manufacturers, importers, and distributors.

June 11, 2026
Malaysia MDA Fully Adopts Electronic Establishment Licenses in 2026
stock photograph of a patient and healthcare professional in a modern Malaysian hospital cardiology department

Indonesia Removes IDAK Renewals Under New Licensing Framework

Indonesia removes IDAK renewals, mandates SDAK and IPAK transitions, and shortens correction timelines under risk-based licensing.

June 11, 2026
Indonesia Removes IDAK Renewals Under New Licensing Framework
Previous
Previous

Get in Touch with Our Medical Devices Team

And discover how we can support you in achieving approval for your medical device or IVD in Singapore.

Request Proposal